Search

Current approved therapeutic strategies for IPF and LC treatment

4.5 (273) · $ 27.50 · In stock

Current approved therapeutic strategies for IPF and LC treatment
Frontiers  Potential targeted therapy based on deep insight into the  relationship between the pulmonary microbiota and immune regulation in lung  fibrosis

Frontiers Potential targeted therapy based on deep insight into the relationship between the pulmonary microbiota and immune regulation in lung fibrosis

PDF) Molecular Mechanisms and Cellular Contribution from Lung

PDF) Molecular Mechanisms and Cellular Contribution from Lung

Massimo DOMINICI  Università degli Studi di Modena e Reggio

Massimo DOMINICI Università degli Studi di Modena e Reggio

Anna SAMARELLI  Università degli Studi di Modena e Reggio Emilia

Anna SAMARELLI Università degli Studi di Modena e Reggio Emilia

Alessandro MARCHIONI  Università degli Studi di Modena e Reggio

Alessandro MARCHIONI Università degli Studi di Modena e Reggio

MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to  mesenchymal transition and reverses lung fibrosis

MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis

Discovery of Novel Selective and Orally Bioavailable Phosphodiesterase-1  Inhibitors for the Efficient Treatment of Idiopathic Pulmonary Fibrosis

Discovery of Novel Selective and Orally Bioavailable Phosphodiesterase-1 Inhibitors for the Efficient Treatment of Idiopathic Pulmonary Fibrosis

hucMSCs treatment prevents pulmonary fibrosis by reducing  circANKRD42-YAP1-mediated mechanical stiffness

hucMSCs treatment prevents pulmonary fibrosis by reducing circANKRD42-YAP1-mediated mechanical stiffness

Linda Manicardi's research works  Polyclinic of Modena, Modena

Linda Manicardi's research works Polyclinic of Modena, Modena

Idiopathic pulmonary fibrosis - ScienceDirect

Idiopathic pulmonary fibrosis - ScienceDirect

Cellular Senescence in Idiopathic Pulmonary Fibrosis

Cellular Senescence in Idiopathic Pulmonary Fibrosis

A Review of the Treatment and Management of Idiopathic Pulmonary Fibrosis

A Review of the Treatment and Management of Idiopathic Pulmonary Fibrosis

PDF) Current Treatment Strategies for Non-Small-Cell Lung Cancer with  Comorbid Interstitial Pneumonia

PDF) Current Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia

Stefania CERRI, Assistant Professor, MD, PhD

Stefania CERRI, Assistant Professor, MD, PhD